Healthcare entity
All 1 tracked stories fall under one category: acquisition. Aurobindo Pharma Ltd. is most often covered alongside Aurobindo Pharma USA, Inc., which appears in 1 of these 1 story. Their average consequence score of 6 sits level with the 6 recorded across the beat in that window.
Last mentioned: Jul 27, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: acquisition. Aurobindo Pharma Ltd. is most often covered alongside Aurobindo Pharma USA, Inc., which appears in 1 of these 1 story. Their average consequence score of 6 sits level with the 6 recorded across the beat in that window. Source depth averages 2 original sources per story, versus 2.2 across the same-window beat baseline. We currently track 1 Healthcare story that mention Aurobindo Pharma Ltd., all published on July 27, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 23 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Aurobindo Pharma Ltd.. Shared-story counts are live from our verified record — not editorial picks.
FTC approval paves the way for Aurobindo Pharma to acquire Lannett Company, adding a 4 billion dose manufacturing facility and complex non-opioid generics portfolio to its network, directly supporting US efforts to boost domestic drug production and address the opioid crisis.
Aurobindo Pharma Ltd. is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
